Rochester seeks European distributor:
This article was originally published in Clinica
Rochester Medical, which last week CE-marked its FemSoft female stress incontinence device, will not be marketing the product in Europe until it has found a distributor. The Stewartville, Minnesota company's device is a latex-free, fluid-filled silicone sleeve, for temporary insertion into the urethra by the user. At the same time American Medical Systems has signed an agreement with UroSurge of Coralville, Iowa to acquire the UroVive bulking agent system. This comprises a bulking agent that delivers hydrogel-filled microballoons to the bladder neck.
You may also be interested in...
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.